Security key
15117F880
Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB)
CUSIP: 15117F880
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock, $0.00001 par value per share
- Total 13F shares
- 336,454
- Total 13F value
- $992,540
- Share change
- +50,684
- SEC-reported price per share
- $2.95
- Number of holders
- 19
- Value change
- -$210
- Number of buys
- 11
- Number of sells
- 6
- Shares outstanding
- 7,966,068
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
19
Top holders
10
CLRB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Cellectar Biosciences, Inc. SEC filings
Cellectar Biosciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 15117F880
Recent filing periods:
Ownership snapshot
Top reported holders of CLRB - Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Rosalind Advisors, Inc.
Disclosed value leader
Orin Hirschman
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G
13F
Lead comparable stake: 5.5%
13D/G row: Rosalind Advisors, Inc.
Showing 1-6 of 15 holder rows.
Quick read
Rosalind Advisors, Inc. leads the comparable SEC ownership view at 5.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Rosalind Advisors, Inc.'s linked filing trail.
Comparable ownership
Top 5
Rosalind Advisors, Inc.
5.5%
INTRACOASTAL CAPITAL, LLC
5%
Orin Hirschman
4.9%
Hexstone Capital LLC
4.9%
Laurence W. Lytton
1.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Rosalind Advisors, Inc. |
13D/G
|
5.5%
|
—
247,715 shares
|
$0 | 31 Dec 2025 |
| INTRACOASTAL CAPITAL, LLC |
13D/G
Mitchell P. Kopin
|
5%
|
—
140,101 shares
|
$0 | 01 Jul 2025 |
| Orin Hirschman |
13D/G
|
4.9%
|
$586,444
2,022,221 shares
|
$0 | 31 Dec 2024 |
| Hexstone Capital LLC |
13D/G
|
4.9%
|
$553,293
216,130 shares
|
+$169,293 | 31 Dec 2025 |
| Laurence W. Lytton |
13D/G
LYTTON LAURENCE W
|
1.6%
|
$250,788
51,391 shares
|
$0 | 30 Jun 2025 |
| ADAR1 Capital Management, LLC |
13D/G
|
0.1%
|
—
2,962 shares
|
$0 | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
19
Shares
336,454
Rows available
19
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
21
Q4 2025 holders
19
Holder diff
-2
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend